Gspoon’s AI technology significantly reduces the time and cost of life science research, redefining the paradigm of the biotech industry through data-driven innovation. By leveraging advanced AI algorithms to analyze vast scientific and clinical datasets, we explore new possibilities in drug discovery, functional ingredient development, and drug repurposing.
GADD systematically integrates and analyzes vast biomedical data through its ontology-based AI knowledge engine. This enables researchers to visualize data intuitively and derive key insights with speed and precision.
An Ontology-Based Knowledge Agent integrates and analyzes complex data through a structured knowledge system, visualizing interactions between genes, proteins, and drugs.
By integrating data in real time and leveraging predictive analytics, we enhance the precision of decision-making.
Exploring new indications for existing drugs accelerates drug development while significantly reducing costs and time
AI-powered predictive modeling pinpoints the most effective drug targets, maximizing clinical trial success.
GADD identifies meaningful drug candidates and functional ingredients from vast datasets.
Supports accurate decision-making based on validated insights.
Achieves up to 80% reduction in development time and 60% cost savings compared to traditional R&D processes.